Children's Oncology Group (COG) Trials for Retinoblastoma

Rachana Shah; Dan S. Gombos

doi:10.1007/978-3-031-77177-4_31

Children's Oncology Group (COG) Trials for Retinoblastoma

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The past decade has witnessed significant multidisciplinary, prospective, clinical, and biological studies of retinoblastoma. The Children's Oncology Group (COG) has successfully opened 6 clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional study of combined intravitreal and systemic chemotherapy for children with retinoblastoma has been initiated.

Original language	English (US)
Title of host publication	Clinical Ophthalmic Oncology
Subtitle of host publication	Retinoblastoma
Publisher	Springer Science+Business Media
Pages	293-300
Number of pages	8
ISBN (Electronic)	9783031771774
ISBN (Print)	9783031771767
DOIs	https://doi.org/10.1007/978-3-031-77177-4_31
State	Published - Jan 1 2025

Keywords

Chemotherapy
Children’s Oncology Group
COG
Trials

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-031-77177-4_31

Cite this

@inbook{b641e1a88cb041aa90dd71a88f2bbe32,

title = "Children's Oncology Group (COG) Trials for Retinoblastoma",

abstract = "The past decade has witnessed significant multidisciplinary, prospective, clinical, and biological studies of retinoblastoma. The Children's Oncology Group (COG) has successfully opened 6 clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional study of combined intravitreal and systemic chemotherapy for children with retinoblastoma has been initiated.",

keywords = "Chemotherapy, Children{\textquoteright}s Oncology Group, COG, Trials",

author = "Rachana Shah and Gombos, \{Dan S.\}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2019, 2024.",

year = "2025",

month = jan,

day = "1",

doi = "10.1007/978-3-031-77177-4\_31",

language = "English (US)",

isbn = "9783031771767",

pages = "293--300",

booktitle = "Clinical Ophthalmic Oncology",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Children's Oncology Group (COG) Trials for Retinoblastoma

AU - Shah, Rachana

AU - Gombos, Dan S.

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2019, 2024.

PY - 2025/1/1

Y1 - 2025/1/1

N2 - The past decade has witnessed significant multidisciplinary, prospective, clinical, and biological studies of retinoblastoma. The Children's Oncology Group (COG) has successfully opened 6 clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional study of combined intravitreal and systemic chemotherapy for children with retinoblastoma has been initiated.

AB - The past decade has witnessed significant multidisciplinary, prospective, clinical, and biological studies of retinoblastoma. The Children's Oncology Group (COG) has successfully opened 6 clinical trials. These include adjuvant therapy for histopathologic risk factors and treatment of Group B, Group C/D, and extraocular retinoblastoma. More recently, a multi-institutional study of combined intravitreal and systemic chemotherapy for children with retinoblastoma has been initiated.

KW - Chemotherapy

KW - Children’s Oncology Group

KW - COG

KW - Trials

UR - https://www.scopus.com/pages/publications/105009085409

UR - https://www.scopus.com/inward/citedby.url?scp=105009085409&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-77177-4_31

DO - 10.1007/978-3-031-77177-4_31

M3 - Chapter

AN - SCOPUS:105009085409

SN - 9783031771767

SP - 293

EP - 300

BT - Clinical Ophthalmic Oncology

PB - Springer Science+Business Media

ER -

Children's Oncology Group (COG) Trials for Retinoblastoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this